Emcure Pharmaceuticals USA, Inc. is a subsidiary of Emcure Pharmaceuticals Limited, one of the leading pharmaceutical companies in India. Established in 2004 and strategically located in Central New Jersey, the United States, the company operates in the Biotechnology, Health Care, and Pharmaceutical industries. Emcure Pharmaceuticals USA, Inc. offers a range of services to the pharmaceutical industry in the US, including product identification, IP registration, and pre-formulation work for the parent company. The company is known for its strengths in API and Formulation R&D, as well as its vertically integrated approach encompassing API and Formulation Manufacturing and Marketing. Emcure Pharmaceuticals USA, Inc. is led by a team of seasoned professionals from the pharmaceutical industry, tapping into the expertise and experience of its key executives. Although details about the last investment and investors are not available, the company's strategic location in the Pharmaceutical Capital of the World provides it with access to a significant scientific talent pool and abundant pharmaceutical resources, bolstering its potential for growth and innovation within the industry.
There is no investment information
No recent news or press coverage available for Emcure Pharmaceuticals USA, Inc.